Consumer medicine information

APOHEALTH Promethazine Antihistamine for Allergy Relief

Promethazine hydrochloride

BRAND INFORMATION

Brand name

APOHealth Promethazine Allergy Relief

Active ingredient

Promethazine hydrochloride

Schedule

S3

 

Consumer medicine information (CMI) leaflet

Please read this leaflet carefully before you start using APOHEALTH Promethazine Antihistamine for Allergy Relief.

What is in this leaflet

This leaflet answers some common questions about APOHEALTH Promethazine Antihistamine for Allergy Relief.

It does not contain all the available information. It does not take the place of talking to your doctor or pharmacist.

All medicines have risks and benefits. Your doctor has weighed the risks of you taking this medicine against the benefits they expect it will provide.

If you have any concerns about this medicine, ask your doctor or pharmacist.

Keep this leaflet with the medicine. You may need to read it again.

What APOHEALTH Promethazine Antihistamine for Allergy Relief is used for

APOHEALTH Promethazine Antihistamine for Allergy Relief is an antihistamine used to treat a number of conditions:

  • allergies – allergic contact dermatitis, hives, hayfever, bites and stings
  • respiratory symptoms due to allergies – runny nose
  • nausea and vomiting – motion sickness
  • assists in the management of the symptoms of chickenpox and measles by acting as a sedative
  • for short-term use for sedation on the advice of a pharmacist or doctor – do not use for more than 7 – 10 days.

Antihistamines help reduce allergic symptoms by preventing the effects of a substance called histamine.

Histamine is produced by the body in response to foreign substances the body is allergic to.

Your doctor or pharmacist may have recommended it for another reason.

Ask your doctor or pharmacist if you have any questions about this medicine.

Before you take APOHEALTH Promethazine Antihistamine for Allergy Relief

When you must not take it

Do not take APOHEALTH Promethazine Antihistamine for Allergy Relief if you have an allergy to:

  • any medicine containing promethazine hydrochloride, medicines of similar properties or belonging to the specific family of chemicals called phenothiazines, other phenothiazines.
  • any of the ingredients listed at the end of this leaflet

Some of the symptoms of an allergic reaction may include:

  • shortness of breath
  • wheezing or difficulty breathing
  • swelling of the face, lips, tongue or other parts of the body
  • rash, itching or hives on the skin.

Any person who is unconscious or in a coma must not be treated with Promethazine Antihistamine for Allergy Relief

Do not take APOHEALTH Promethazine Antihistamine for Allergy Relief if you are also taking monoamine oxidase inhibitors, a type of medicine used to treat depression.

Do not take APOHEALTH Promethazine Antihistamine for Allergy Relief if you have jaundice.

Do not take this medicine if you are receiving or have received high doses of other CNS depressant medications (for example, drugs that are used to treat anxiety and sleep disorders).

Do not take this medicine if you have slowed breathing or heart rate of any cause.

Any person who is unconscious or in a coma must not be treated with APOHEALTH Promethazine Antihistamine for Allergy Relief.

Do not give APOHEALTH Promethazine Antihistamine for Allergy Relief to newborn or premature babies.

Do not give to children under six years of age, due to the potential for fatal respiratory depression.

Do not take APOHEALTH Promethazine Antihistamine for Allergy Relief if you are breastfeeding of planning to breastfeed. It passes into the breast milk and there is a possibility that the baby may be affected.

Do not take APOHEALTH Promethazine Antihistamine for Allergy Relief after the expiry date (EXP) printed on the pack. If you take this medicine after the expiry date has passed, it may not work as well.

Do not take APOHEALTH Promethazine Antihistamine for Allergy Relief if the packaging is torn or shows signs of tampering.

Before you start to take it

Tell your doctor or pharmacist if you have allergies to:

  • any other medicines
  • any other substances, such as foods, preservatives or dyes

Tell your doctor or pharmacist if you have or have had any medical conditions, especially the following:

  • kidney or liver disease
  • parkinson’s disease
  • underactive thyroid gland (hypothyroidism)
  • tumour growing in adrenal glands (phechromocytoma)
  • autoimmune disorder (myasthenia gravis)
  • epilepsy
  • cardiovascular disease/cardiac failure
  • blood pressure problems
  • low white blood cell count (agranulocytosis)
  • bladder problems
  • breathing problems
  • glaucoma – an eye condition
  • prostate problems
  • stomach ulcer or blockage

develop a fever or an infection to confirm if laboratory tests are required to check your blood count

Tell your doctor or pharmacist if you plan to have surgery.

Tell your doctor or pharmacist if you take sedatives.

Take any medicines for any other condition

Have any personal or family history of heart disease

Have an irregular heartbeat

If you experience an allergic reaction, seek medical help right away.

Caution must be exercised when using APOHEALTH Promethazine Antihistamine for Allergy Relief due the risk of sedation.

If you experience fever, sore throat or any other infection, you should inform your doctor or pharmacist immediately and undergo a complete blood count. Treatment should be discontinued if any marked changed are observed in the blood count.

Check with your doctor or pharmacist if you are a woman of childbearing age and not using effective contraception.

Tell your doctor or pharmacist if you are pregnant or intend to become pregnant. APOHEALTH Promethazine Antihistamine for Allergy Relief is not recommended for use during pregnancy. It may affect your developing baby if you take it during pregnancy. If there is a need to consider APOHEALTH Promethazine Antihistamine for Allergy Relief during pregnancy, your doctor or pharmacist will discuss with you the benefits and risks of taking it

Taking other medicines

Tell your doctor or pharmacist if you are taking any other medicines, including any that you get without a prescription from your pharmacy, supermarket or health food shop.

Some medicines and APOHEALTH Promethazine Antihistamine for Allergy Relief may interfere with each other. APOHEALTH Promethazine Antihistamine for Allergy Relief may increase the sedative effect of some drugs. These include:

  • medicines used to treat depression, especially monoamine oxidase inhibitors and tricyclic antidepressants
  • medicines used to help you sleep and relax (sedatives and hypnotics)
  • opioid analgesics, medicines used to treat pain
  • other antihistamines
  • alcohol and alcohol containing medicines
  • medicines for the treatment of irregular heartbeats (antiarrhythmics)
  • medicines that help with your mood (antidepressants)
  • medicines used to help with mental illness (antipsychotics)
  • medicines to treat infections (antimicrobials)
  • medicines used to treat nausea and vomiting like metoclopramide
  • medicines used to relieve muscle spasm like carisoprodol and cyclobenzaprine.
  • Medicines used for the treatment of epilepsy or seizures
  • Medicine used to treat acid indigestion such as magnesium, aluminium and calcium salts, oxides and hydroxides.
  • Medicines used to smooth muscle contractions in the gastrointestinal tract (antispasmodics)

These medicines may be affected by APOHEALTH Promethazine Antihistamine for Allergy Relief or may affect how well it works. You may need different amounts of your medicines, or you may need to take different medicines.

Your doctor and pharmacist have more information on medicines to be careful with or avoid while taking this medicine.

How to take APOHEALTH Promethazine Antihistamine for Allergy Relief

How much to take

Follow all directions given to you by your doctor and pharmacist carefully. They may differ from the information contained in this leaflet.

APOHEALTH Promethazine Antihistamine for Allergy Relief tablets are recommended for adults and children over 6 years of age.

APOHEALTH Promethazine Antihistamine for Allergy Relief tablets should not be given to children aged between 6 and 11 years of age, except on the advice of your doctor or pharmacist.

It is recommended that the lowest effective dose of APOHEALTH Promethazine Antihistamine for Allergy Relief be used in children 6 years of age or older.

Allergic Disorder
Adults and children over 12 years of age: One to three 25mg tablets as a single dose at night, or one to two 10mg tablets, two to three times daily.

Children 6-12 years: One to two 10mg tablets as a single dose at night, or one 10mg tablet, two to three times daily.

Sedation
For short term use on the advice of a doctor or pharmacist. Do not take for more than 7 – 10 consecutive days.

Adults and children over 12 years of age: One to three 25mg tablets as a single dose at night.

Children 6-12 years: One to two 10mg tablets as a single dose at night.

Travel Sickness
Adults and children over 12 years of age: One 25mg tablet.

Children 6-12 years: One 10mg tablet.

To be taken the night before travel and repeated after 6 to 8 hours on the following day if required.

Nausea and Vomiting
Adults and children over 12 years of age: One 25mg tablet every 4 to 6 hours to a maximum daily dose of four 25mg tablets (100 mg in total).

Children 6-12 years: One 10mg tablet every 4 to 6 hours to a maximum daily dose of two 10mg tablets (20 mg in total).

If you do not understand the instructions on the carton or label, ask your doctor or pharmacist for help.

Do not take more than the recommended dose.

Use this drug only as recommended. Do not exceed the recommended dose. There have been case reports of promethazine abuse.

Use in the elderly

If you are over 65 years of age, talk to your doctor or pharmacist about how much to take. Elderly patients are more likely to have side effects from taking these medicines.

How to take it

Swallow APOHEALTH Promethazine Antihistamine for Allergy Relief whole with a full glass of water.

How long to take it

APOHEALTH Promethazine Antihistamine for Allergy Relief should not usually be taken for more than 10 days in a row. If your symptoms persist, see your doctor or pharmacist for advice.

If you forget to take it

If you are taking APOHEALTH Promethazine Antihistamine for Allergy Relief for an allergic disorder and you forget to take your bedtime dose, you may need to take your dose in two or three smaller doses during the following day. Check with your doctor or pharmacist.

If you are taking APOHEALTH Promethazine Antihistamine for Allergy Relief for travel sickness or nausea and vomiting, take your dose as soon as you remember.

If you are taking APOHEALTH Promethazine Antihistamine for Allergy Relief for sedation, take your dose as soon as you remember. Be careful because you may still be affected in the morning.

Do not take a double dose to make up for the dose that you missed. This may be harmful.

If you are not sure what to do, ask your doctor or pharmacist.

If you have trouble remembering to take your medicine, ask your pharmacist for some hints.

If you take too much (overdose)

Immediately telephone your doctor or the Poisons Information Centre (telephone 13 11 26) for advice or go to Accident and Emergency at the nearest hospital, if you think that you or anyone else may have taken too much APOHEALTH Promethazine Antihistamine for Allergy Relief.

Do this even if there are no signs of discomfort or poisoning. You may need urgent medical attention.

If you take too much APOHEALTH Promethazine Antihistamine for Allergy Relief, you may experience:

Adults

  • drowsiness
  • convulsions and/or tremors
  • difficulty breathing
  • unconsciousness
  • acute anxiety
  • hallucinations
  • heart palpitations, chest pain and/or rapid pulse
  • dizziness
  • nausea
  • cold sweats

Children

  • over-excitement
  • shaky and unsteady movements
  • convulsions and/or tremors
  • hallucinations
  • difficulty breathing
  • unconsciousness
  • high fever
  • heart palpitations, chest pain and/or rapid pulse
  • dizziness
  • nausea
  • cold sweats

While you are taking APOHEALTH Promethazine Antihistamine for Allergy Relief

Things you must do

APOHEALTH Promethazine Antihistamine for Allergy Relief may cause skin to be more sensitive to the sun. You should protect your skin from sun or exposure to bright sunlight.

Tell any other doctor, dentist or pharmacist who are treating you that you are taking APOHEALTH Promethazine Antihistamine for Allergy Relief.

If you are about to be started on any new medicine, tell your doctor or pharmacist that you are taking APOHEALTH Promethazine Antihistamine for Allergy Relief.

If you plan to have surgery that needs a general anaesthetic, tell your doctor or dentist that you are taking this medicine.

If you become pregnant while taking this medicine, stop taking it and tell your doctor immediately.

Talk to your doctor or pharmacist if your symptoms do not improve. Your doctor or pharmacist will assess your condition and decide if you should continue to take the medicine.

Things you must not do

Do not give APOHEALTH Promethazine Antihistamine for Allergy Relief to anyone else, even if they have the same condition as you.

Do not take APOHEALTH Promethazine Antihistamine for Allergy Relief to treat any other complaints unless your doctor or pharmacist tells you to.

Do not drink alcohol while taking APOHEALTH Promethazine Antihistamine for Allergy Relief. The sedation effects of alcohol may be increased.

Do not take more than the recommended dose unless your doctor or pharmacist tells you to.

Things to be careful of

APOHEALTH Promethazine Antihistamine for Allergy Relief is a known sedative and may cause drowsiness in some people.

Make sure you know how you react to APOHEALTH Promethazine Antihistamine for Allergy Relief before you drive a car, operate machinery, or do anything else that could be dangerous if you experience drowsiness, dizziness and blurred vision. If this occurs do not drive or operate machinery.

If you have a single dose at bedtime, you may still be affected in the morning.

A very serious health problem called neuroleptic malignant syndrome (NMS) may happen. Stop treatment and call your doctor right away if you have high fever, muscle cramps or stiffness, dizziness, very bad headache, fast heartbeat, confusion, agitation, hallucinations, or are sweating a lot.

Avoid alcohol while taking APOHEALTH Promethazine Antihistamine for Allergy Relief. The sedation effects of alcohol may be increased.

Children and the elderly are especially sensitive to the effects of antihistamines.

Side effects

APOHEALTH Promethazine Antihistamine for Allergy Relief may have unwanted side effects in some people. All medicines can have side effects.

Sometimes they are serious, most of the time they are not. You may need medical treatment if you get some side effects.

Tell your doctor or pharmacist as soon as possible if you do not feel well while you are taking APOHEALTH Promethazine Antihistamine for Allergy Relief.

Tell your doctor or pharmacist if you notice any of the following and they worry you:

  • dry mouth, nose & throat
  • stomach upset
  • loss of appetite
  • nausea or vomiting
  • diarrhoea or constipation
  • tiredness or sleepiness
  • restlessness
  • confusion
  • anxiety
  • blurred vision
  • congested nose
  • headache
  • involuntary muscle movement (dystonia)
  • nightmares in children
  • increased sensitivity to the sun
  • dizziness

These are mild side effects of the medicine and are short-lived.

Tell your doctor or pharmacist immediately if you notice any of the following:

  • fever
  • excessive sweating
  • dizziness
  • nausea
  • cold sweats
  • low blood pressure
  • difficulty breathing
  • difficulty passing urine
  • irregular heartbeat
  • very fast or forceful heartbeats (palpitations)
  • chest pain
  • rapid pulse
  • Blood and Lymphatic System Disorders -eosinophilia which is an increase in the number of eosinophils (a type of white blood cells) found in the blood test. Thrombocytopenia which is a decrease in the number of platelets (cells in the blood that help with clotting) found in a blood test, which can lead to bleeding and bruising (thrombocytopenic purpura)
  • jaundice – yellow tinge to the skin or eyes
  • tremors or convulsions
  • tinnitus – buzzing, hissing, ringing or other persistent noise in the ears
  • confusion
  • twitching or jerking muscles
  • dizziness, lightheadedness
  • severe headache
  • muscle cramps or stiffness
  • anxiety
  • agitation
  • seizures (fits)
  • hallucinations
  • agitation
  • nervousness and irritability
  • neuroleptic malignant syndrome (NMS) – see subheading “Things to be careful of”
  • severe uncontrollable muscular movements

The above list includes serious side effects that may require medical attention. These side effects are rare.

If any of the following happen, tell your doctor immediately or go to Accident and Emergency at your nearest hospital:

  • wheezing or difficulty breathing
  • swelling of the face, lips, tongue, or other parts of the body/severe allergic reaction where adrenaline is required for treatment (anaphylaxis)
  • skin rashes

The above list includes symptoms of an allergic reaction. You may need urgent medical attention or hospitalisation. Allergic reactions are very rare.

Tell your doctor or pharmacist if you notice anything that is making you feel unwell. Other side effects not listed above may occur in some patients.

Do not be alarmed by the lists of possible side effects. You may not experience any of them.

Ask your doctor or pharmacist if you have any questions.

After using APOHEALTH Promethazine Antihistamine for Allergy Relief

Storage

Keep your medicine in the original container until it is time to take it. If you take your medicine out of the pack it will not keep as well.

Keep your tablets in a cool dry place where the temperature stays below 30°C.

Do not store APOHEALTH Promethazine Antihistamine for Allergy Relief or any other medicine in the bathroom or near a sink. Do not leave it in the car on hot days or on window sills. Heat and dampness can destroy some medicines.

Keep the medicine where children cannot reach it. A locked cupboard at least one-and-a-half meters above the ground is a good place to store medicines.

Disposal

If your doctor or pharmacist tells you to stop taking APOHEALTH Promethazine Antihistamine for Allergy Relief or if it has passed the expiry date, ask your pharmacist what to do with any medicine you have left over.

Product description

What it looks like

APOHEALTH Promethazine 10 Antihistamine for Allergy Relief tablets:

  • 10 mg tablets – round, white to off-white, flat faced, beveled- edged tablets, debossed 10 on one side and plain on the reverse side.

APOHEALTH Promethazine 25 Antihistamine for Allergy relief tablets:

  • 25 mg tablets – round, white to off-white, flat faced, beveled- edged tablets, debossed 25 on one side and plain on the reverse side.

Both are available in blister packs of 50 tablets.

Ingredients

Active ingredient:

  • 10 mg tablets – 10 mg of promethazine hydrochloride
  • 25 mg tablets – 25 mg of promethazine hydrochloride

Inactive ingredients:

  • magnesium stearate
  • microcelac-100 (containing lactose monohydrate & microcrystalline cellulose)

Supplier

Arrow Pharma Pty Ltd
15-17 Chapel Street
Cremorne VIC 3121
www.arrowpharma.com.au

This leaflet was prepared in September 2022

Australian registration number:

APOHEALTH Promethazine 10 Antihistamine for Allergy Relief 10 mg – AUST R 337352

APOHEALTH Promethazine 25 Antihistamine for Allergy Relief 25 mg – AUST R 337353

Published by MIMS November 2022

BRAND INFORMATION

Brand name

APOHealth Promethazine Allergy Relief

Active ingredient

Promethazine hydrochloride

Schedule

S3

 

1 Name of Medicine

Promethazine hydrochloride.

2 Qualitative and Quantitative Composition

APOHealth Promethazine 10 antihistamine for Allergy Relief tablets contain 10 mg of promethazine hydrochloride and APOHealth Promethazine 25 antihistamine for Allergy Relief tablets contain 25 mg of promethazine hydrochloride.

Excipients with known effect.

Lactose monohydrate.
For the full list of excipients, see Section 6.1 List of Excipients.

3 Pharmaceutical Form

APOHealth Promethazine 10 antihistamine for Allergy Relief 10 mg tablets are round, white to off-white, flat faced, bevelled-edged tablets, debossed 10 on one side and plain on the reverse side.
APOHealth Promethazine 25 antihistamine for Allergy Relief 25 mg tablets are round, white to off-white, flat faced, bevelled-edged tablets, debossed 25 on one side and plain on the reverse side.

4 Clinical Particulars

4.1 Therapeutic Indications

Allergies.

Treatment of allergic conditions including some allergic reactions to drugs, urticaria and allergic contact dermatitis, and allergic reactions to insect bites and stings.

Upper respiratory tract.

Relief of excessive secretion in the upper respiratory tract as a result of hayfever and allergic rhinitis.

Nausea and vomiting.

Antiemetic for vomiting from various causes, including postoperative vomiting, irradiation sickness, drug induced nausea and motion sickness.

Sedation.

For short-term use under the advice of a doctor or pharmacist. Do not use for more than 7 to 10 consecutive days.

Other.

Promethazine hydrochloride has sedative effects and can be used in the symptomatic management of measles and chickenpox.
Promethazine hydrochloride can be used as a pre-anaesthetic medication for the prevention and control of postoperative vomiting.

4.2 Dose and Method of Administration

This product should not be given to children under 6 years of age (see Section 4.3 Contraindications; Section 4.4 Special Warnings and Precautions for Use). This product is not suitable for children aged 6-11 years unless on pharmacist or medical advice (see Section 4.4 Special Warnings and Precautions for Use). Dosage varies according to the condition being treated and the individual's response.

Allergic disorder.

Adults and children over 12 years of age.

25 to 75 mg as a single dose at night, or 10 to 20 mg two to three times daily.

Children 6-12 years.

10 to 25 mg as a single dose at night, or 10 mg two to three times daily.

Sedation.

Adults and children over 12 years of age.

25 to 75 mg as a single dose at night.

Children 6-12 years.

10 to 25 mg as a single dose at night.

Travel sickness.

Adults and children over 12 years of age.

25 mg.

Children 6-12 years.

10 mg.
To be taken the night before travel and repeated after 6 to 8 hours on the following day if required.

Nausea and vomiting.

Adults and children over 12 years of age.

25 mg every 4 to 6 hours to a maximum daily dose of 100 mg.

Children 6-12 years.

10 mg every 4 to 6 hours to a maximum daily dose of 25 mg.

4.3 Contraindications

APOHealth Promethazine 10 antihistamine for Allergy Relief and APOHealth Promethazine 25 antihistamine for Allergy Relief is contraindicated for use in patients with a history of hypersensitivity to the drug substance, substances of similar chemical structure, other phenothiazines or hypersensitivity to the other ingredients in the formulation.
This product is contraindicated for use in:
children under 6 years of age because of the potential for fatal respiratory depression. Post-marketing cases of respiratory depression, including fatalities, have been reported with the use of promethazine in paediatric patients less than 6 years of age. A wide range of weight-based doses of promethazine hydrochloride have resulted in respiratory depression in these patients. (See Section 4.4 Special Warnings and Precautions for Use);
lactating women;
patients taking monoamine oxidase inhibitors (MAOIs) up to 14 days previously (see Section 4.5 Interactions with Other Medicines and Other Forms of Interactions);
jaundice induced by other phenothiazine derivatives;
patients in coma or suffering from CNS depression of any cause or who have received high doses of other CNS depressants.
See Section 4.5 Interactions with Other Medicines and Other Forms of Interactions for additional information.

4.4 Special Warnings and Precautions for Use

Caution is advised in patients with:
cardiovascular disease;
acute or chronic respiratory impairment as promethazine may thicken or dry lung secretions and impair expectoration;
epilepsy;
hypertensive crisis;
narrow angle glaucoma;
stenosing peptic ulcer;
symptomatic prostatic hypertrophy;
bladder neck obstruction;
pyloroduodenal obstruction.
Hypersensitivity reactions including anaphylaxis, urticaria and angioedema have been reported with promethazine use. In case of allergic reaction, treatment with promethazine must be discontinued and appropriate symptomatic treatment initiated - Section 4.5.
Promethazine should be avoided in patients with Parkinson's disease, hypothyroidism, cardiac failure, pheochromocytoma, myasthenia gravis, or prostate hypertrophy, or in patients with a history of agranulocytosis.
Caution must be exercised when using H1-antihistamines such as promethazine due to the risk of sedation.
Combined use with other sedative medicinal products is not recommended (see Section 4.5).
Promethazine may delay the early diagnosis of intestinal obstruction or increased intracranial pressure through the suppression of vomiting.
Promethazine may mask the warning signs of ototoxicity caused by ototoxic drugs e.g. salicylates.
Promethazine may increase the effects of alcohol. Alcohol should be avoided during treatment.
QT interval prolongation has been reported with phenothiazines.
Phenothiazine derivatives may potentiate QT interval prolongation which increases the risk of onset of serious ventricular arrhythmias of the torsade de pointes type, which is potentially fatal (sudden death). QT prolongation is exacerbated, in particular, in the presence of bradycardia, hypokalaemia, and acquired (i.e. drug induced) QT prolongation. If the clinical situation permits, medical and laboratory evaluations should be performed to rule out possible risk factors before initiating treatment with a phenothiazine derivative and as deemed necessary during treatment (see Section 4.8 Adverse Effects (Undesirable Effects)).
See Section 4.5 Interactions with Other Medicines and Other Forms of Interactions for additional information.
Prolonged administration of any phenothiazine may result in tardive dyskinesia, particularly in the elderly and children.
Alcohol and alcohol-containing medicines should be avoided while on this medicine (see Section 4.5).
Phenothiazines may be additive with, or may potentiate the action of, other CNS depressants such as opiates or other analgesics, barbiturates or other sedatives, general anesthetics, or alcohol.
As agranulocytosis has been reported, regular monitoring of the complete blood count is recommended. The occurrence of unexplained infections or fever may be evidence of blood dyscrasia (see Section 4.5), and requires immediate haematological investigation.
All patients should be advised that, if they experience fever, sore throat or any other infection, they should inform their physician immediately and undergo a complete blood count. Treatment should be discontinued if any marked changes (hyperleucocytosis, granulocytopenia) are observed in the blood count.
There have been case reports of drug abuse with promethazine hydrochloride. The risk of abuse is greater in patients with a history of drug abuse.
As with neuroleptics, neuroleptic malignant syndrome (NMS) characterised by hyperthermia, extrapyramidal disorders, muscle rigidity, altered mental status, autonomic nervous instability and elevated CPK, may occur. As this syndrome is potentially fatal, promethazine hydrochloride must be discontinued immediately and intensive clinical monitoring and symptomatic treatment should be initiated.

Hypertensive crisis.

Promethazine hydrochloride should be used with caution, if at all, in these patients.
Solar dermatitis has been reported following oral doses of promethazine hydrochloride in patients with eczema or a tendency to rheumatism.
Due to the risk of photosensitivity, exposure to the sun or ultraviolet light should be avoided during or shortly after treatment.

Epilepsy.

Epileptic patients may experience increased severity of convulsions.

Use in hepatic impairment.

Caution is advised in patients with hepatic insufficiency. It should be avoided in patients with liver dysfunction.

Use in renal impairment.

Caution is advised in patients with renal failure or insufficiency. It should be avoided in patients with renal dysfunction.

Use in the elderly.

The elderly may experience paradoxical excitation with promethazine hydrochloride. The elderly are more likely to have CNS depressive side effects, including confusion and are more susceptible to the anti-muscarinic effects of antihistamines, including hypotension (see Section 4.3 Contraindications).

Paediatric use.

This product should not be used in children under 6 years of age due to the potential for fatal respiratory depression (see Section 4.3 Contraindications).
Caution should be exercised when administering promethazine to children 6 years of age or older because of the potential for fatal respiratory depression, including central and obstructive apnoea and reduced arousal. Respiratory depression and apnoea, sometimes fatal, are associated with promethazine even if individualised weight-based dosing is used.
Concomitant administration of other drugs with respiratory depressant effects should be avoided.
The use of promethazine hydrochloride should be avoided in children and adolescents with signs and symptoms suggestive of Reye's syndrome.
Excessive dosages of antihistamines in children may cause hallucinations, convulsions and sudden death. Children may experience paradoxical excitation with promethazine hydrochloride.
It is recommended that the lowest effective dose of promethazine hydrochloride be used in paediatric patients 6 years of age or older.

Effects on laboratory tests.

No data available.

4.5 Interactions with Other Medicines and Other Forms of Interactions

Promethazine will enhance the action of any anticholinergic agent, tricyclic antidepressant, sedative or hypnotic. Promethazine hydrochloride may cause drowsiness and will enhance the sedative effects of CNS depressants (including alcohol, barbiturates, hypnotics, opioid analgesics, anxiolytic sedatives and neuroleptics), and have additive anti-muscarinic actions with other anti-muscarinic drugs (atropine, tricyclic antidepressants). Interactions between promethazine hydrochloride and monoamine oxidase inhibitors and tricyclic antidepressants (TCAs) may prolong and intensify the anticholinergic and CNS depressive effects. Alcohol should be avoided during treatment. Combination with alcohol enhances the sedative effects of H1 antihistamines. Promethazine may interfere with immunological urine pregnancy tests to produce false-positive or false-negative results.
Special caution is required when promethazine is used concurrently with drugs known to cause QT prolongation (such as antiarrhythmics, antimicrobials, antidepressants, antipshychotics) to avoid exacerbation of risk of QT prolongation.

Cytochrome P450 2D6 metabolism.

Some phenothiazines are moderate inhibitors of CYP2D6. There is a possible pharmacokinetic interaction between inhibitors of CYP2D6, such as phenothiazines, and CYP2D6 substrates. Co administration of promethazine with amitriptyline/ amitriptylinoxide, a CYP2D6 substrate, may lead to an increase in the plasma levels of amitriptyline/ amitriptylinoxide. Monitor patients for dose-dependent adverse reactions associated with amitriptyline/ amitriptylinoxide.
Promethazine should be avoided in patients taking monamine oxidase inhibitors within the previous 14 days, and monamine oxidase inhibitors should be avoided while using promethazine.

Seizure threshold-lowering drugs.

Concomitant use of seizure-inducing drugs or seizure threshold lowering drugs should be carefully considered due to the severity of the risk for the patient (see Section 4.4).

Gastro-intestinal agents that are not absorbed (magnesium, aluminium and calcium salts, oxides and hydroxides).

Reduced gastro-intestinal absorption of phenothiazines may occur. Such gastrointestinal agents should not be taken at the same time as phenothiazines (at least 2 hours apart, if possible).

Drugs with anticholinergic properties.

Concomitant use of promethazine with drugs with anticholinergic properties enhances the anticholinergic effect.

4.6 Fertility, Pregnancy and Lactation

Effects on fertility.

There are no relevant fertility data available in animals.
(Category C)
The use of promethazine is not recommended during pregnancy and in women of childbearing potential not using contraception. Promethazine hydrochloride should be used in pregnancy only if the potential benefits to the patient are weighed against the possible risk to the foetus.
Promethazine hydrochloride, owing to its pharmacological effects, has caused or may be suspected of causing harmful effects on the human foetus or neonate without causing malformations. These effects may be reversible.
When promethazine hydrochloride has been given in high doses during late pregnancy, promethazine hydrochloride has caused prolonged neurological disturbances in the infant.
Promethazine hydrochloride is excreted in breast milk. There are risks of neonatal irritability and excitement. Therefore, it should not be used for breastfeeding women.

4.7 Effects on Ability to Drive and Use Machines

Promethazine considerably affects the ability to drive a vehicle and operate machines. Promethazine hydrochloride may cause drowsiness, dizziness and blurred vision and can considerably affect the ability of driving a vehicle and operating machines. Drowsiness may continue the following day. Those affected should not drive or operate machinery.

4.8 Adverse Effects (Undesirable Effects)

CNS effects.

CNS depressive effects of promethazine hydrochloride include sedation and impaired performance (impaired driving performance, poor work performance, incoordination, reduced motor skills and impaired information processing). Performance may be impaired in the absence of sedation and may persist the morning after a night time dose.
The CNS stimulatory effects of promethazine hydrochloride may include anxiety, hallucinations, appetite stimulation, muscle dyskinesias and activation of epileptogenic foci.
High doses of promethazine hydrochloride may cause nervousness, tremor, insomnia, agitation and irritability.

Anticholinergic effects.

Side effects of promethazine hydrochloride associated with cholinergic blockage include dryness of the eyes, mouth and nose, blurred vision, urinary hesitancy and retention, constipation and tachycardia.

More common reactions.

Gastrointestinal disorders.

Dry mouth, epigastric distress, loss of appetite, nausea, vomiting, constipation, diarrhoea.

Nervous system disorders.

Sedation or somnolence, restlessness, dizziness, lassitude, incoordination, fatigue.

Eye disorders.

Blurred vision.

Less common reactions.

Cardiovascular.

Tachycardia, bradycardia, faintness.

Skin and subcutaneous tissue disorders.

Contact dermatitis (topical), urticaria, angioneurotic oedema, pruritus.

Haematological.

Leucopenia, agranulocytosis, aplastic anaemia, thrombocytopenic purpura.

Nervous system disorders.

Tinnitus, euphoria, nervousness, insomnia, convulsive seizures, oculogyric crises, excitation, catatonic-like states, hysteria, tardive dyskinesia.

Respiratory.

Marked irregular respiration.

Reactions with frequency unknown.

Skin and subcutaneous tissue disorders.

Rash, photosensitivity.

Hepatobiliary disorders.

Jaundice cholestatic.

Renal and urinary disorders.

Urinary retention.

Nervous system disorders.

Neuroleptic malignant syndrome, somnolence, dizziness headaches, tic-like movements of the head and face, extrapyramidal symptoms including muscle spasm, dystonia, including oculogyric crisis, usually transitory are commoner in children and young adults, and usually occur within the first 4 days of treatment or after dosage increases. Anticholinergic effects such as ileus paralytic, risk of urinary retention, dry mouth, constipation, accommodation disorder. The elderly are particularly susceptible to the anticholinergic effects and confusion due to promethazine.

Immune system disorders.

Allergic reactions, including urticaria, rash, pruritus, angioedema and anaphylactic reaction have been reported.

Metabolism and nutrition disorders.

Anorexia, decreased appetite.

Blood and lymphatic system disorders.

Blood dyscrasias including haemolytic anaemia, agranulocytosis, leukopenia, eosinophilia, thrombocytopenia (including thrombocytopenic purpura).

Psychiatric disorders.

Infants, newborns and premature are susceptible to the anticholinergic effects of promethazine, while other children may display paradoxical hyperexcitability, restlessness, nightmares, disorientation.

Cardiac disorders.

Palpitations, arrhythmias, QT Prolongation, torsade de pointes.

Respiratory, thoracic and mediastinal disorders.

Respiratory depression, nasal congestion.

Vascular disorders.

Hypotension.

General disorders and administration site conditions.

Tiredness.

Severe or life threatening reactions.

Agranulocytosis, anaphylaxis.

Reporting suspected adverse effects.

Reporting suspected adverse reactions after registration of the medicinal product is important. It allows continued monitoring of the benefit-risk balance of the medicinal product. Healthcare professionals are asked to report any suspected adverse reactions at www.tga.gov.au/reporting-problems.

4.9 Overdose

Symptoms of severe overdosage are variable. The chief sign of acute poisoning from ingestion of an overdose of promethazine hydrochloride is unconsciousness which is commonly delayed. In addition, convulsions, hallucinations, delirium, acute anxiety, psychotic reactions, extreme hyperaesthesia and hyperalgesia with extensor plantar responses may occur. Anticholinergic action may cause tachycardia, flushed skin, dry mouth and sometimes mydriasis and urinary retention.
In adults, CNS depression is more common, with drowsiness, coma, convulsions, progressing to respiratory failure or cardiovascular collapse.
High doses can cause ventricular arrhythmias including QT prolongation and torsade de pointes (see Section 4.8 Adverse Effects (Undesirable Effects)).
In infants and children, CNS stimulation predominates over CNS depression causing ataxia, excitement, tremors, psychoses, hallucinations, convulsions and possibly hyperpyrexia, which may be followed by deepening coma and cardiorespiratory collapse.

Treatment.

Similar to that of other phenothiazines. In the event of overdose of promethazine, take all appropriate measures immediately. Symptomatic supportive therapy is indicated and maintenance of adequate ventilation should be instituted if necessary.
For information on the management of overdose, contact the Poisons Information Centre on 13 11 26 (Australia).

5 Pharmacological Properties

5.1 Pharmacodynamic Properties

Mechanism of action.

Promethazine hydrochloride, a phenothiazine derivative, is a long acting antihistamine with mild atropine-like anticholinergic effects and some anti-serotonin effects, and because of its marked effect on the central nervous system (CNS), it acts as an antiemetic, hypnotic, tranquilliser, and a potentiator of anaesthetics, hypnotics, sedatives and analgesics.

Clinical trials.

No data available.

5.2 Pharmacokinetic Properties

Absorption.

Promethazine hydrochloride is well absorbed after oral administration. Peak plasma concentrations are reached 2 to 3 hours after administration by this route, although there is low systemic bioavailability after oral administration, due to high first-pass metabolism in the liver.

Distribution.

Promethazine hydrochloride crosses the blood brain barrier and the placenta, and is distributed into breast milk. It is highly bound to plasma proteins (76-93%).

Metabolism.

Promethazine hydrochloride undergoes extensive metabolism, predominantly to promethazine hydrochloride sulfoxide and also to N-desmethyl promethazine hydrochloride.

Excretion.

It is excreted slowly via the urine and bile, mainly as metabolites. Elimination half-lives of 5 to 14 hours have been reported. The antihistamine action has been reported to be between 4 and 12 hours.

5.3 Preclinical Safety Data

Genotoxicity.

No data available.

Carcinogenicity.

No data available.

6 Pharmaceutical Particulars

6.1 List of Excipients

APOHealth Promethazine 10 antihistamine for Allergy Relief and APOHealth Promethazine 25 antihistamine for Allergy Relief tablets contain the following inactive ingredients: magnesium stearate; microcelac-100 (containing lactose monohydrate and microcrystalline cellulose).

6.2 Incompatibilities

Incompatibilities were either not assessed or not identified as part of the registration of this medicine.

6.3 Shelf Life

In Australia, information on the shelf life can be found on the public summary of the Australian Register of Therapeutic Goods (ARTG). The expiry date can be found on the packaging.

6.4 Special Precautions for Storage

Store below 30°C.

6.5 Nature and Contents of Container

APOHealth Promethazine 10 antihistamine for Allergy Relief and APOHealth Promethazine 25 antihistamine for Allergy Relief tablets are supplied in blister packs (PVC/PVDC/Al) containing 50 tablets.

6.6 Special Precautions for Disposal

In Australia, any unused medicine or waste material should be disposed of by taking to your local pharmacy.

6.7 Physicochemical Properties

Promethazine hydrochloride is a white or faintly yellow, practically odourless, crystalline powder. It is very soluble in water, freely soluble in alcohol and in chloroform, and practically insoluble in ether.

Chemical structure.

Its structural formula is:

CAS number.

CAS: 58-33-3.

7 Medicine Schedule (Poisons Standard)

S3 - Pharmacist Only Medicine.

Summary Table of Changes